Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of OCTN1 and MDR1 polymorphisms on verapamil pharmacokinetics and ECG in healthy volunteers
KCT0000420Phase 4Recruiting
- Sponsor
- Ministry of Health & Welfare
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of verapamil, sponsored by Ministry of Health & Welfare. Primary endpoints: Pharmacokinetic parameters of verapamil and ECG response to verapamil. Started Dec 2011; status: recruiting.
02
Drugs
verapamil
Beyond the preview
Go deeper on KCT0000420.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000420.